Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening

British Journal of Cancer

Volumn 116, Issue 1, 2017, Pages 44-49

  Van Der Vlugt, Manon ^a   Grobbee, Esmée J ^b   Bossuyt, Patrick M M ^a   Bongers, Evelien ^c   Spijker, Wolfert ^d   Kuipers, Ernst J ^b   Lansdorp Vogelaar, Iris ^b   Essink Bot, Marie Louise ^a   Spaander, Manon C W ^b   Dekker, Evelien ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Foundation of Population screening Mid West   (Netherlands)

^d Nationwide Screening Organization for the South western Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; EVALUATION STUDY; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SOCIAL STATUS; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; IMMUNOHISTOCHEMISTRY; MASS SCREENING; METABOLISM; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; PROCEDURES; REGISTER; STATISTICS AND NUMERICAL DATA;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT PARTICIPATION; REGISTRIES;

EID: 85001874166     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.399     Document Type: Article

References (39)

1. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV (2007) Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99: 1462-1470
2. Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA. Task Force on Community Preventive Services (2008) Client-Directed Interventions to Increase Community Demand for Breast, Cervical, and Colorectal Cancer Screening. Am J Prev Med 35: S34-S55
3. Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C (2012) High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 10: 633-638
4. Denis B, Gendre I, Perrin P (2015) Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. J Med Screen 22: 76-82
5. Denters MJ, Bossuyt PM, Deutekom M, Fockens P, Dekker E (2015) Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer. Eur J Cancer Prev 24: 176-179
6. Denters MJ, Deutekom M, Bossuyt PM, van Rijn AF, Fockens P, Dekker E (2013) Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening. Cancer Epidemiol 37: 330-335
7. Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, Stegeman I, Kraaijenhagen RA, Fockens P, van Leerdam ME, Dekker E, Kuipers EJ (2012) Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 107: 1570-1578
8. El-Haddad B, Dong F, Kallail KJ, Hines RB, Ablah E (2015) Association of marital status and colorectal cancer screening participation in the USA. Colorectal Dis 17: 108-114
9. Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, McDuffie JR, Ostbye T, Yancy WS Jr (2011) Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol 106: 1125-1134
10. Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJ, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MC (2016) Comparison of OC-Sensor and FOB-gold in population-based colorectal cancer screening based on FIT. Gut; e-pub ahead of print 9 August 2016 doi:10.1136/gutjnl-2016-311819
11. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 348: 1472-1477
12. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 1: CD001216
13. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103: 1541-1549
14. Hurtado JL, Bacigalupe A, Calvo M, Esnaola S, Mendizabal N, Portillo I, Idigoras I, Millán E, Arana-Arri E (2015) Social inequalities in a population based colorectal cancer screening programme in the Basque Country. BMC Public Health 15: 1021
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90
16. Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde CN, Quesenberry CP, Levin TR, Mysliwiec PA (2016) Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med 164: 456-463
17. Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME (2014) Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 109: 1257-1264
18. Kobayashi LC, Wardle J, von Wagner C (2014) Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English longitudinal study of ageing. Prev Med 61: 100-105
19. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet 348: 1467-1471
20. Launoy G, Duffy SW, Prevost TC, Bouvier V (1998) Detection of cancer, sensitivity of the test and sensitivity of the screening program. Rev Epidemiol Sante Publique 46: 420-426
21. Leuraud K, Jezewski-Serra D, Viguier J, Salines E (2013) Colorectal cancer screening by guaiac faecal occult blood test in France: evaluation of the programme two years after launching. Cancer Epidemiol 37: 959-967
22. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C (2015a) Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 64: 282-291
23. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C (2015b) Predictors of repeat participation in the NHS bowel cancer screening programme. Br J Cancer 112: 199-206
24. Mandel JS, Bond TH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371
25. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, Ramsell P, Patnick J, Weller DP (2012) Performance measures in three rounds of the English bowel cancer screening pilot. Gut 61: 101-107
26. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S, Chan AT (2013) Long-term colorectalcancer incidence and mortality after lower endoscopy. N Engl J Med 369: 1095-1105
27. Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G (2010) Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health 64: 318-324
28. Pornet C, Denis B, Perrin P, Gendre I, Launoy G (2014) Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program. Br J Cancer 111: 2152-2155
29. Santare D, Kojalo I, Huttunen T, Rikacovs S, Rucevskis P, Boka V, Leja M (2015) Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol 27: 536-543
30. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR (2013) Long-term mortality after screening for colorectal cancer. N Engl J Med 369: 1106-1114
31. Steele RJ, McClements PL, Libby G, Carey FA, Fraser CG (2013) Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis 16: 28-32
32. Stegeman I, van Doorn SC, Mundt MW, Mallant-Hent RC, Bongers E, Elferink MA, Fockens P, Stroobants AK, Bossuyt PM, Dekker E (2015) Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer Epidemiol 39: 388-393
33. Tinmouth J, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt C, Lu Y, Mackinnon M, Paszat L, Rabeneck L (2015) Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous non-responders. Int J Cancer 136: E697-E703
34. van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AH, Reijerink JC, van Ballegooijen M, van Leerdam ME (2013) What influences the decision to participate in colorectalcancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer 49: 2321-2330
35. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135(1): 82-90
36. Wee CC, Mc Carthy EP, Philips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41: 23-29
37. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, the National Polyp Study Workgroup (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981
38. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, ShiW, Bond JH, Schapiro M, Panish JF, Stewart ET,Waye JD (2012) Colonoscopic polypectomy and long-term prevention of colorectalcancer deaths. N Engl J Med 366: 687-696
39. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, Fedato C, Saugo M, Dei Tos AP (2015) Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 64: 784-790